Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation

Clinical trial NCT01208337 · COMPLETED

Trial details

NCT number: NCT01208337
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Evidence of Liver Transplantation Rejection ALEMTUZUMAB

Start date: 2007-04-01
Primary completion: 2014-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.